Literature DB >> 22374953

Genome sequences of four divergent multidrug-resistant Acinetobacter baumannii strains isolated from patients with sepsis or osteomyelitis.

Daniel V Zurawski1, Mitchell G Thompson, Christin N McQueary, Malcolm N Matalka, Jason W Sahl, David W Craft, David A Rasko.   

Abstract

Acinetobacter baumannii is a Gram-negative bacterium that causes nosocomial infections worldwide, with recent prevalence and higher frequency in wounded military personnel. Four A. baumannii strains from the Walter Reed Army Medical Center (WRAMC) isolated between 2008 and 2009 were sequenced, representing diverse, multidrug-resistant isolates from osteomyelitis or septic patients.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22374953      PMCID： PMC3294875          DOI： 10.1128/JB.06749-11

Source DB:  PubMed          Journal:  J Bacteriol        ISSN： 0021-9193            Impact factor:   3.490


  14 in total

1.  Genomewide analysis of divergence of antibiotic resistance determinants in closely related isolates of Acinetobacter baumannii.

Authors:  Mark D Adams; E Ricky Chan; Neil D Molyneaux; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2010-06-07       Impact factor: 5.191

2.  Comparison of outbreak and nonoutbreak Acinetobacter baumannii strains by genotypic and phenotypic methods.

Authors:  L Dijkshoorn; H Aucken; P Gerner-Smidt; P Janssen; M E Kaufmann; J Garaizar; J Ursing; T L Pitt
Journal:  J Clin Microbiol       Date:  1996-06       Impact factor: 5.948

Review 3.  Clinical impact and pathogenicity of Acinetobacter.

Authors:  M-L Joly-Guillou
Journal:  Clin Microbiol Infect       Date:  2005-11       Impact factor: 8.067

4.  Comparison of Acinetobacter baumannii isolates from the United Kingdom and the United States that were associated with repatriated casualties of the Iraq conflict.

Authors:  Jane F Turton; Mary E Kaufmann; Martin J Gill; Rachel Pike; Paul T Scott; Joel Fishbain; David Craft; Gregory Deye; Scott Riddell; Luther E Lindler; Tyrone L Pitt
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

5.  Global spread of carbapenem-resistant Acinetobacter baumannii.

Authors:  Paul G Higgins; Cathrin Dammhayn; Meredith Hackel; Harald Seifert
Journal:  J Antimicrob Chemother       Date:  2009-12-08       Impact factor: 5.790

6.  Clinical outcomes of carbapenem-resistant Acinetobacter baumannii bloodstream infections: study of a 2-state monoclonal outbreak.

Authors:  L Silvia Munoz-Price; Teresa Zembower; Sudhir Penugonda; Paul Schreckenberger; Mary Alice Lavin; Sharon Welbel; Dana Vais; Mirza Baig; Sunita Mohapatra; John P Quinn; Robert A Weinstein
Journal:  Infect Control Hosp Epidemiol       Date:  2010-10       Impact factor: 3.254

Review 7.  An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii.

Authors:  Lenie Dijkshoorn; Alexandr Nemec; Harald Seifert
Journal:  Nat Rev Microbiol       Date:  2007-12       Impact factor: 60.633

8.  Comparative genome sequence analysis of multidrug-resistant Acinetobacter baumannii.

Authors:  Mark D Adams; Karrie Goglin; Neil Molyneaux; Kristine M Hujer; Heather Lavender; Jennifer J Jamison; Ian J MacDonald; Kristienna M Martin; Thomas Russo; Anthony A Campagnari; Andrea M Hujer; Robert A Bonomo; Steven R Gill
Journal:  J Bacteriol       Date:  2008-10-17       Impact factor: 3.490

9.  CloVR: a virtual machine for automated and portable sequence analysis from the desktop using cloud computing.

Authors:  Samuel V Angiuoli; Malcolm Matalka; Aaron Gussman; Kevin Galens; Mahesh Vangala; David R Riley; Cesar Arze; James R White; Owen White; W Florian Fricke
Journal:  BMC Bioinformatics       Date:  2011-08-30       Impact factor: 3.307

10.  Comparative analysis of Acinetobacters: three genomes for three lifestyles.

Authors:  David Vallenet; Patrice Nordmann; Valérie Barbe; Laurent Poirel; Sophie Mangenot; Elodie Bataille; Carole Dossat; Shahinaz Gas; Annett Kreimeyer; Patricia Lenoble; Sophie Oztas; Julie Poulain; Béatrice Segurens; Catherine Robert; Chantal Abergel; Jean-Michel Claverie; Didier Raoult; Claudine Médigue; Jean Weissenbach; Stéphane Cruveiller
Journal:  PLoS One       Date:  2008-03-19       Impact factor: 3.240
View more
  27 in total

1.  Resources for Genetic and Genomic Analysis of Emerging Pathogen Acinetobacter baumannii.

Authors:  Larry A Gallagher; Elizabeth Ramage; Eli J Weiss; Matthew Radey; Hillary S Hayden; Kiara G Held; Holly K Huse; Daniel V Zurawski; Mitchell J Brittnacher; Colin Manoil
Journal:  J Bacteriol       Date:  2015-04-06       Impact factor: 3.490

2.  Prolonging culture to 15 days improves bacterial detection in bone and joint infections.

Authors:  L Drago; E De Vecchi; L Cappelletti; C Vassena; M Toscano; M Bortolin; R Mattina; C L Romanò
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-06-09       Impact factor: 3.267

3.  Identification of small molecules inhibiting diguanylate cyclases to control bacterial biofilm development.

Authors:  Karthik Sambanthamoorthy; Chunyuan Luo; Nagarajan Pattabiraman; Xiarong Feng; Benjamin Koestler; Christopher M Waters; Thomas J Palys
Journal:  Biofouling       Date:  2013-10-11       Impact factor: 3.209

4.  Small Molecule Potentiation of Gram-Positive Selective Antibiotics against Acinetobacter baumannii.

Authors:  Sara E Martin; Roberta J Melander; Christopher M Brackett; Alison J Scott; Courtney E Chandler; Catherine M Nguyen; Bradley M Minrovic; Sarah E Harrill; Robert K Ernst; Colin Manoil; Christian Melander
Journal:  ACS Infect Dis       Date:  2019-04-26       Impact factor: 5.084

5.  Validation of a novel murine wound model of Acinetobacter baumannii infection.

Authors:  Mitchell G Thompson; Chad C Black; Rebecca L Pavlicek; Cary L Honnold; Matthew C Wise; Yonas A Alamneh; Jay K Moon; Jennifer L Kessler; Yuanzheng Si; Robert Williams; Suleyman Yildirim; Benjamin C Kirkup; Romanza K Green; Eric R Hall; Thomas J Palys; Daniel V Zurawski
Journal:  Antimicrob Agents Chemother       Date:  2013-12-16       Impact factor: 5.191

6.  Molecular characterization of multidrug resistant hospital isolates using the antimicrobial resistance determinant microarray.

Authors:  Tomasz A Leski; Gary J Vora; Brian R Barrows; Guillermo Pimentel; Brent L House; Matilda Nicklasson; Momtaz Wasfy; Mohamed Abdel-Maksoud; Chris Rowe Taitt
Journal:  PLoS One       Date:  2013-07-25       Impact factor: 3.240

7.  Antimicrobial resistance determinants in Acinetobacter baumannii isolates taken from military treatment facilities.

Authors:  Chris Rowe Taitt; Tomasz A Leski; Michael G Stockelman; David W Craft; Daniel V Zurawski; Benjamin C Kirkup; Gary J Vora
Journal:  Antimicrob Agents Chemother       Date:  2013-11-18       Impact factor: 5.191

8.  Augmenting the Activity of Macrolide Adjuvants against Acinetobacter baumannii.

Authors:  Veronica B Hubble; Kyle R Bartholomew; Alexander W Weig; Sara M Brackett; Samantha L Barlock; Anne E Mattingly; Ansley M Nemeth; Roberta J Melander; Christian Melander
Journal:  ACS Med Chem Lett       Date:  2020-08-12       Impact factor: 4.345

9.  Decontaminating surfaces with atomized disinfectants generated by a novel thickness-mode lithium niobate device.

Authors:  Monika Kumaraswamy; Sean Collignon; Carter Do; Janie Kim; Victor Nizet; James Friend
Journal:  Appl Microbiol Biotechnol       Date:  2018-05-26       Impact factor: 5.560

10.  Evolution of a pathogen: a comparative genomics analysis identifies a genetic pathway to pathogenesis in Acinetobacter.

Authors:  Jason W Sahl; John D Gillece; James M Schupp; Victor G Waddell; Elizabeth M Driebe; David M Engelthaler; Paul Keim
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.